)
Edge15 May 2026
TOMRA: Closing the Loop
The story of TOMRA: from reverse vending machine pioneer to global technology for deposit systems, recycling, and resource optimization.
Avicanna
Avicanna (AVCN) investor relations material
Avicanna Q1 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q1 2026 earnings summary14 May, 2026
Executive summary
Achieved record quarterly revenue and gross profit in Q1 2026, driven by Canadian commercial growth and proprietary product expansion.
Continued advancement of pharmaceutical pipeline, medical affairs, and international platform.
MyMedi.ca platform delivered its fourth consecutive quarter of growth, with highest unit sales on record.
Expanded product portfolio and commercial listings across medical and adult-use channels in Canada.
Financial highlights
Q1 2026 revenue reached $6.68 million, up 6% year-over-year, marking the highest in company history.
Gross profit was $3.84 million, a 7% increase year-over-year; gross margin improved to 58%.
Adjusted EBITDA loss of $0.15 million, down from adjusted EBITDA income of $0.43 million in Q1 2025, due to revenue mix shift and higher SG&A expenses.
Working capital deficit reduced by $0.96 million to $0.32 million, supporting inventory growth.
Outlook and guidance
U.S. rescheduling of medical cannabis aligns with strategy and supports future R&D and clinical initiatives.
Ongoing monitoring of regulatory developments and assessment of U.S. market entry pathways.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Avicanna
- 2025 saw improved margins, reduced losses, and all AGM proposals passed for future growth.AVCN
AGM 20268 May 2026 - Gross margin rose to 53% in 2025, with near break-even EBITDA and global expansion underway.AVCNQ4 20257 Apr 2026
- Expanding globally with proprietary cannabinoid medicines and platforms, targeting medical markets.AVCNLife Sciences Virtual Investor Forum23 Mar 2026
- Poised for scale-up in 2026 with new technologies, clinical progress, and global expansion.AVCNStatus Update17 Dec 2025
- Revenue and unit sales grew, international reach expanded, and new IP was secured in Q3 2025.AVCNQ3 202526 Nov 2025
- Record revenue, margin gains, and global expansion set the stage for 2025 profitability.AVCNQ4 202424 Nov 2025
- Gross margin rose to 51% in Q2 2025, with positive six-month adjusted EBITDA and expanded product reach.AVCNQ2 202525 Aug 2025
- Revenue up 75% to $18.8M, gross margin 57%, and EBITDA loss narrowed in Q3 2024.AVCNQ3 202413 Jun 2025
- Q2 revenue up 85%, gross margin 49%, and adjusted EBITDA loss narrowed by 65%.AVCNQ2 202413 Jun 2025
Next Avicanna earnings date
Q2 202613 Aug, 2026
Avicanna
Next Avicanna earnings date
Q2 202613 Aug, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage